Credit Agricole’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $55.2M | Buy |
609,995
+450,452
| +282% | +$37.7M | 0.11% | 146 |
|
|
2026
Q1 | $12.8M | Sell |
159,543
-77,493
| -33% | -$6.39M | 0.03% | 343 |
|
|
2025
Q4 | $20.2M | Buy |
237,036
+174,317
| +278% | +$14.3M | 0.05% | 280 |
|
|
2025
Q3 | $4.88M | Buy |
+62,719
| New | +$4.9M | 0.01% | 568 |
|
|
2025
Q1 | $5.74M | Sell |
79,161
-241,662
| -75% | -$17.3M | 0.02% | 509 |
|
|
2024
Q4 | $23.8M | Sell |
320,823
-220,744
| -41% | -$15.5M | 0.07% | 201 |
|
|
2024
Q3 | $35.7M | Sell |
541,567
-447,409
| -45% | -$32.5M | 0.15% | 106 |
|
|
2024
Q2 | $91.4M | Buy |
988,976
+951,182
| +2,517% | +$84.2M | 0.49% | 45 |
|
|
2024
Q1 | $3.27M | Buy |
37,794
+17,681
| +88% | +$1.49M | 0.04% | 315 |
|
|
2023
Q4 | $1.53M | Buy |
20,113
+8,186
| +69% | +$570K | 0.02% | 348 |
|
|
2023
Q3 | $826K | Buy |
11,927
+11,677
| +4,671% | +$938K | 0.01% | 362 |
|
|
2023
Q2 | $23.6K | Sell |
250
-605
| -71% | -$52.6K | ﹤0.01% | 583 |
|
|
2023
Q1 | $70.7K | Sell |
855
-2,543
| -75% | -$200K | ﹤0.01% | 475 |
|
|
2022
Q4 | $254K | Sell |
3,398
-1,326
| -28% | -$102K | 0.01% | 405 |
|
|
2022
Q3 | $390K | Sell |
4,724
-7,186
| -60% | -$691K | 0.01% | 357 |
|
|
2022
Q2 | $1.13M | Sell |
11,910
-1,055
| -8% | -$109K | 0.03% | 291 |
|
|
2022
Q1 | $1.53M | Sell |
12,965
-44,423
| -77% | -$4.98M | 0.03% | 270 |
|
|
2021
Q4 | $7.43M | Buy |
57,388
+1,617
| +3% | +$189K | 0.12% | 129 |
|
|
2021
Q3 | $6.31M | Sell |
55,771
-26,014
| -32% | -$2.97M | 0.12% | 131 |
|
|
2021
Q2 | $8.47M | Buy |
81,785
+705
| +0.9% | +$66.5K | 0.17% | 107 |
|
|
2021
Q1 | $6.78M | Sell |
81,080
-2,375
| -3% | -$201K | 0.17% | 106 |
|
|
2020
Q4 | $7.61M | Sell |
83,455
-4,143
| -5% | -$344K | 0.25% | 84 |
|
|
2020
Q3 | $6.99M | Buy |
87,598
+7,488
| +9% | +$584K | 0.37% | 71 |
|
|
2020
Q2 | $5.54M | Sell |
80,110
-7,721
| -9% | -$549K | 0.35% | 77 |
|
|
2020
Q1 | $5.52M | Sell |
87,831
-34,824
| -28% | -$2.51M | 0.47% | 51 |
|
|
2019
Q4 | $9.54M | Sell |
122,655
-114,420
| -48% | -$8.93M | 0.53% | 48 |
|
|
2019
Q3 | $17.4M | Buy |
237,075
+12,336
| +5% | +$867K | 0.84% | 34 |
|
|
2019
Q2 | $13.8M | Buy |
224,739
+5,211
| +2% | +$315K | 0.74% | 36 |
|
|
2019
Q1 | $14M | Buy |
219,528
+37,722
| +21% | +$2.15M | 0.76% | 30 |
|
|
2018
Q4 | $9.28M | Buy |
181,806
+37,056
| +26% | +$1.87M | 0.53% | 39 |
|
|
2018
Q3 | $8.4M | Buy |
144,750
+87,600
| +153% | +$4.28M | 0.4% | 51 |
|
|
2018
Q2 | $2.77M | Buy |
+57,150
| New | +$2.67M | 0.19% | 116 |
|
|
2017
Q4 | – | Sell |
-541,584
| Closed | -$19.7M | – | 604 |
|
|
2017
Q3 | $19.7M | Buy |
541,584
+44,586
| +9% | +$1.7M | 0.07% | 302 |
|
|
2017
Q2 | $19.6M | Sell |
496,998
-17,409
| -3% | -$635K | 0.06% | 314 |
|
|
2017
Q1 | $16.1M | Buy |
514,407
+104,991
| +26% | +$3.29M | 0.05% | 410 |
|
|
2016
Q4 | $12.8M | Sell |
409,416
-1,401,888
| -77% | -$45.4M | 0.04% | 423 |
|
|
2016
Q3 | $72.8M | Sell |
1,811,304
-20,511
| -1% | -$772K | 0.24% | 96 |
|
|
2016
Q2 | $60.9M | Buy |
1,831,815
+112,533
| +7% | +$3.85M | 0.23% | 103 |
|
|
2016
Q1 | $50.6M | Buy |
1,719,282
+478,362
| +39% | +$13.2M | 0.24% | 107 |
|
|
2015
Q4 | $32.7M | Sell |
1,240,920
-119,034
| -9% | -$3.09M | 0.15% | 152 |
|
|
2015
Q3 | $32.2M | Buy |
1,359,954
+800,874
| +143% | +$19.3M | 0.16% | 139 |
|
|
2015
Q2 | $13.3M | Sell |
559,080
-72,030
| -11% | -$1.63M | 0.06% | 338 |
|
|
2015
Q1 | $15M | Sell |
631,110
-176,268
| -22% | -$3.95M | 0.07% | 327 |
|
|
2014
Q4 | $17.5M | Buy |
807,378
+480,882
| +147% | +$9.66M | 0.07% | 306 |
|
|
2014
Q3 | $5.56M | Sell |
326,496
-664,290
| -67% | -$10.5M | 0.02% | 579 |
|
|
2014
Q2 | $14.2M | Buy |
990,786
+214,992
| +28% | +$2.91M | 0.06% | 349 |
|
|
2014
Q1 | $9.59M | Sell |
775,794
-85,332
| -10% | -$985K | 0.04% | 454 |
|
|
2013
Q4 | $9.44M | Buy |
861,126
+649,938
| +308% | +$7.33M | 0.04% | 475 |
|
|
2013
Q3 | $2.45M | Buy |
+211,188
| New | +$2.47M | 0.01% | 788 |
|
Other funds holding EW
Credit Agricole's EW Position: Q2 2026 in Review
Credit Agricole increased its Edwards Lifesciences (EW) stake by 282% in Q2 2026, buying an estimated $37.7M and bringing the position to 609,995 shares worth $55.2M. The position accounts for 0.11% of the portfolio, ranked #146.
Credit Agricole first reported a position in EW in Q3 2013 and has held it in 49 quarters since. The position peaked at $91.4M in Q2 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Credit Agricole held 609,995 shares of Edwards Lifesciences worth $55.2M as of Q2 2026.
- Credit Agricole bought 450,452 Edwards Lifesciences shares in Q2 2026, an estimated $37.7M.
- Edwards Lifesciences made up 0.11% of Credit Agricole's portfolio in Q2 2026, its #146 holding.
- Credit Agricole first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 49 quarters since.
- Credit Agricole's Edwards Lifesciences position peaked at $91.4M in Q2 2024.
- 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.